BioPharmX engages KGK Synergize, Inc. to manage its Canadian phase 4 study for Violet molecular iodine breast health supplement

MENLO PARK, Calif., April 4, 2016 /CNW/ — BioPharmX Corporation (NYSE MKT: BPMX), specialty pharmaceutical company developing products for use in…